Gala Pharmaceuticals, Inc. engages in the development, research, and commercialization of products derived from the Hemp and Cannabis Plant. It also provides testing or analytical chemistry tools for chemical, plant, soil, and liquid composition analysis; and provides genetic fingerprinting and sequencing of various crop species. Its services include analytical testing, molecular services, and consulting and training. The company was founded on March 10, 2010 and is headquartered in Irvine, CA.
Company profile
Ticker
GLPH
Exchange
Website
CEO
Maqsood Rehman
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Gala Global Inc., Gala Pharmaceuticals Inc.
SEC CIK
Corporate docs
GLPH stock data
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
7 Sep 21
8-K
Departure of Directors or Certain Officers
4 May 20
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
18 Oct 19
NT 10-Q
Notice of late quarterly filing
16 Oct 19
8-K/A
Other Events
23 Aug 19
10-Q
2019 Q2
Quarterly report
23 Jul 19
NT 10-Q
Notice of late quarterly filing
15 Jul 19
10-Q
2019 Q1
Quarterly report
30 Apr 19
NT 10-Q
Notice of late quarterly filing
17 Apr 19
10-K
2018 FY
Annual report
15 Apr 19
Latest ownership filings